Vicarious Surgical Inc. (RBOT) Stock Analysis & Investment Frameworks
Vicarious Surgical Inc. (RBOT) stock analysis on Invetso. Review Vicarious Surgical Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Vicarious Surgical Inc. Company Overview
- Exchange: Other OTC
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
Vicarious Surgical Inc. Key Financial Metrics
- Market Cap: $9716.00
- Revenue: $N/A
- ROE: -333.19%
- ROIC: -396.87%
- Dividend Yield: N/A
About Vicarious Surgical Inc.
Vicarious Surgical Inc. is dedicated to the development and commercialization of advanced single-incision surgical robotics. Their innovative technology is designed to give surgeons a virtual, immersive presence within the patient's body, facilitating highly precise and minimally invasive operations. The company's primary product, the Vicarious System, is a sophisticated single-incision robot engineered specifically for procedures like ventral hernia repair. Established in 2014, Vicarious Surgical Inc. operates from its corporate headquarters in Waltham, Massachusetts.